220 related articles for article (PubMed ID: 37627123)
1. Expression of Claudins in Preneoplastic Conditions of the Gastrointestinal Tract: A Review.
Ouban A; Arabi TZ
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627123
[TBL] [Abstract][Full Text] [Related]
2. [Study of claudins and prognostic factors in some gastrointestinal diseases].
Gyorffy H
Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.
Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial leak in Barrett's esophagus.
Mullin JM; Valenzano MC; Trembeth S; Allegretti PD; Verrecchio JJ; Schmidt JD; Jain V; Meddings JB; Mercogliano G; Thornton JJ
Dig Dis Sci; 2006 Dec; 51(12):2326-36. PubMed ID: 17103306
[TBL] [Abstract][Full Text] [Related]
5. Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.
Németh Z; Szász AM; Tátrai P; Németh J; Gyorffy H; Somorácz A; Szíjártó A; Kupcsulik P; Kiss A; Schaff Z
J Histochem Cytochem; 2009 Feb; 57(2):113-21. PubMed ID: 18854598
[TBL] [Abstract][Full Text] [Related]
6. hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract.
Lastraioli E; Iorio J; Petrelli F; Tomezzoli A; Battista S; Ambrosio MR; Chiudinelli M; De Salvatore F; Messerini L; Villanacci V; Saragoni L; Arcangeli A;
Curr Issues Mol Biol; 2022 Mar; 44(3):1326-1331. PubMed ID: 35723312
[TBL] [Abstract][Full Text] [Related]
7. Ion transport and barrier function in a telomerase-immortalized human nondysplastic, Barrett's cell line (BAR-T).
Jovov B; Orlando GS; Tobey NA; Brown KL; Djukic Z; Carson JL; Brighton LE; Orlando RC
Dis Esophagus; 2009; 22(5):386-95. PubMed ID: 19673046
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
9. The claudin family of proteins in human malignancy: a clinical perspective.
Ding L; Lu Z; Lu Q; Chen YH
Cancer Manag Res; 2013 Nov; 5():367-75. PubMed ID: 24232410
[TBL] [Abstract][Full Text] [Related]
10. High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.
Abu-Farsakh S; Wu T; Lalonde A; Sun J; Zhou Z
BMC Gastroenterol; 2017 Feb; 17(1):33. PubMed ID: 28212604
[TBL] [Abstract][Full Text] [Related]
11. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ
Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
14. Claudins and gastric carcinogenesis.
Iravani O; Tay BW; Chua PJ; Yip GW; Bay BH
Exp Biol Med (Maywood); 2013 Apr; 238(4):344-9. PubMed ID: 23759999
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett's esophagus: a matched case-control study.
Helminen O; Melkko J; Saarnio J; Sihvo E; Kuopio T; Ohtonen P; Kauppila JH; Karttunen TJ; Huhta H
Virchows Arch; 2022 Sep; 481(3):467-476. PubMed ID: 35614270
[TBL] [Abstract][Full Text] [Related]
16. cCPE Fusion Proteins as Molecular Probes to Detect Claudins and Tight Junction Dysregulation in Gastrointestinal Cell Lines, Tissue Explants and Patient-Derived Organoids.
Waldow A; Beier LS; Arndt J; Schallenberg S; Vollbrecht C; Bischoff P; Farrera-Sal M; Loch FN; Bojarski C; Schumann M; Winkler L; Kamphues C; Ehlen L; Piontek J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514167
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
18. Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors).
Ishida M; Kushima R; Okabe H
Oncol Rep; 2009 Jan; 21(1):113-7. PubMed ID: 19082451
[TBL] [Abstract][Full Text] [Related]
19. Claudins in genitourinary tract neoplasms: mechanisms, prognosis, and therapeutic prospects.
Arabi TZ; Fawzy NA; Sabbah BN; Ouban A
Front Cell Dev Biol; 2023; 11():1308082. PubMed ID: 38188015
[TBL] [Abstract][Full Text] [Related]
20. Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms.
Odze RD; Maley CC
Arch Pathol Lab Med; 2010 Jun; 134(6):896-906. PubMed ID: 20524867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
